Spherix Inc (SPEX):企業の財務・戦略的SWOT分析

◆英語タイトル:Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C4724
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Spherix Inc (SPEX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Spherix Inc (Spherix) is an intellectual property development company. The company has diversified commercial platform for protected technologies. It owns, develops, acquires and monetizes intellectual property. Prior to the business of commercialization of intellectual property, the company was engaged in the business of drug development for clinical trials. The company currently owns the patents in the wireless communications and telecommunication sectors which includes Wi-Fi, base station functionality, antenna technology, cellular technology, internet access, and video and data transmission. Spherix, Inc. is headquartered in Maryland, the US.

Spherix Inc Key Recent Developments

Aug 15,2017: Spherix Announces the Addition of Dr. Scott T. Tagawa to Company’s Technology Advisory Board
Jul 27,2017: Spherix Announces That Anthony Hayes Joins the Board of Directors at Hoth Therapeutics
Jul 25,2017: Spherix Announces the Formation of a Technology Advisory Board in Area of BioPharmaceutical Opportunities
Jun 27,2017: Spherix Issues Letter to Shareholders

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Spherix Inc – Key Facts 5
Spherix Inc – Key Employees 6
Spherix Inc – Key Employee Biographies 7
Spherix Inc – Major Products and Services 8
Spherix Inc – History 9
Spherix Inc – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 12
Company Overview 12
Spherix Inc – Business Description 13
Spherix Inc – Corporate Strategy 14
Spherix Inc – SWOT Analysis 15
SWOT Analysis – Overview 15
Spherix Inc – Strengths 15
Spherix Inc – Weaknesses 16
Spherix Inc – Opportunities 17
Spherix Inc – Threats 18
Spherix Inc – Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios – Capital Market Ratios 20
Financial Ratios – Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios – Interim Ratios 24
Financial Ratios – Ratio Charts 25
Spherix Inc, Recent Deals Summary 26
Section 4 – Company’s Recent Developments 27
Aug 15, 2017: Spherix Announces the Addition of Dr. Scott T. Tagawa to Company’s Technology Advisory Board 27
Aug 15, 2017: Spherix Announces the Addition of Dr. Scott T. Tagawa to Company’s Technology Advisory Board 28
Jul 27, 2017: Spherix Announces That Anthony Hayes Joins the Board of Directors at Hoth Therapeutics 29
Jul 25, 2017: Spherix Announces the Formation of a Technology Advisory Board in Area of BioPharmaceutical Opportunities 30
Jun 27, 2017: Spherix Issues Letter to Shareholders 31
Section 5 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Spherix Inc, Key Facts 5
Spherix Inc, Key Employees 6
Spherix Inc, Key Employee Biographies 7
Spherix Inc, Major Products and Services 8
Spherix Inc, History 9
Spherix Inc, Subsidiaries 11
Spherix Inc, Key Competitors 19
Spherix Inc, Ratios based on current share price 20
Spherix Inc, Annual Ratios 21
Spherix Inc, Annual Ratios (Cont...1) 22
Spherix Inc, Interim Ratios 24
Spherix Inc, Recent Deals Summary 26
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List of Figures
Spherix Inc, Performance Chart (2013 - 2017) 23
Spherix Inc, Ratio Charts 25

★海外企業調査レポート[Spherix Inc (SPEX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Matsumotokiyoshi Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Matsumotokiyoshi Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Matsumotokiyoshi Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Summit Therapeutics Plc (SUMM):企業の財務・戦略的SWOT分析
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …
  • America Movil, SA DE C.V.:企業の戦略・SWOT・財務情報
    America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report Summary America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Siem Offshore Inc (SIOFF):石油・ガス:M&Aディール及び事業提携情報
    Summary Siem Offshore Inc (Siem Offshore), a subsidiary of Siem Industries Inc is a marine service provider that owns and operates modern offshore support vessels for the offshore oil and gas industries. The company offers shipbuilding, ordering and delivery of new vessels, acquisition of modern sec …
  • Ei Towers SpA:企業の戦略・SWOT・財務分析
    Ei Towers SpA - Strategy, SWOT and Corporate Finance Report Summary Ei Towers SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Vigo Coal Company Incorporated:企業の戦略・SWOT・財務情報
    Vigo Coal Company Incorporated - Strategy, SWOT and Corporate Finance Report Summary Vigo Coal Company Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • FluoroPharma Medical Inc (FPMI):企業の財務・戦略的SWOT分析
    Summary FluoroPharma Medical Inc (FluoroPharma) is a molecular imaging company that develops and commercialize proprietary medical diagnostic imaging products. The company develops breakthrough positron emission tomography imaging agents for the assessment and detection of acute and chronic forms of …
  • Aesica Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Aesica Pharmaceuticals Ltd (Aesica), a subsidiary of Consort Medical plc is a contract development and manufacturing organization (CDMO). It manufactures and develops generic active pharmaceutical ingredients (APIs) and finished dosage forms. Aesica’s services portfolio encompass pre-formula …
  • Noni B Ltd (NBL):企業の財務・戦略的SWOT分析
    Noni B Ltd (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Oncodesign SA (ALONC):企業の財務・戦略的SWOT分析
    Summary Oncodesign SA (Oncodesign) is a bio pharmaceutical company that discovers drugs to treat diseases with unmet medical needs. It is investigating LRRK2 inhibitor to treat Parkinson’s disease, RIPK2 inhibitor against autoimmune diseases, MNK1/2 inhibitor targeting cancer. The company offers dru …
  • Amgen Inc (AMGN)-製薬・医療分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • NIH Office of Technology Transfer-製薬・医療分野:企業M&A・提携分析
    Summary NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biolog …
  • Orchard Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Orchard Therapeutics Ltd (Orchard) is an integrated commercial-stage biotechnology company that develops gene therapies for the treatment of serious and life-threatening orphan diseases. Its pipeline products include Strimvelis, an autologous ex vivo gammaretroviral gene therapy for the trea …
  • Campanile UK Ltd:企業の戦略・SWOT・財務分析
    Campanile UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Campanile UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PDC Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    PDC Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary PDC Energy Inc (PDC Energy) is an oil and gas company that offers production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal …
  • Welspun Corp Ltd:企業の戦略・SWOT・財務情報
    Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CoreCivic, Inc. (CXW):企業の財務・戦略的SWOT分析
    CoreCivic, Inc. (CXW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pall Corp-医療機器分野:企業M&A・提携分析
    Summary Pall Corp (Pall), a subsidiary of Danaher Corporation, is a supplier of filtration, separation and purification products and technologies to remove solid, liquid and gaseous contaminants from liquids and gases. Its major products include biochemicals, bioreactors, breathers, canisters, cartr …
  • Itochu Chemical Frontier Corp-製薬・医療分野:企業M&A・提携分析
    Summary Itochu Chemical Frontier Corp (ICF), formerly Ando Kaseihin KK, a subsidiary of Itochu Corporation, is a chemical company that manufactures and markets chemical products. The company operates in intermediate chemical division, silicone and adhesive division, osaka and nagoya division, perfor …
  • Fair Isaac Corp (FICO):企業の財務・戦略的SWOT分析
    Fair Isaac Corp (FICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆